The technique of tra n s p l a n t ation of encap s u l ated cells has progressed to the use of va rious endocrine tissues. 1 S e m i p e rm e able membranes used for capsules allow tra n sp o rt of low -m o l e c u l a r-weight substances, such as nu t rients and neuro t ra n s m i t t e rs, but prevent the inwa rd diffusion of both the humoral and cellular elements of the i m mune system. 2 3 Th e re fo re, the cells in the capsules are i s o l ated from the host immune system, wh i ch fa c i l i t at e s xe n ograft surv ival. In addition, the ability to re m ove an implant is an adva n t age in the event of infection, ove rd o s e, or idiopathic side effe c t s . 2 3 In the central nervous system, this technique has been used in the tre atment of Pa rk i n s o n 's disease in animal models 1 1 and for re d u c t i o n of pain. 2 2 In the present study, AtT-2 0 5 and pro o p i o m e l a n o c o rt i n ge n e -t ra n s fected Neuro 2 A , 1 6 wh i ch are both mouse cell lines that secrete adre n o c o rt i c o t ropic hormone (AC T H ) and ␤-e n d o rphin, we re encap s u l ated and transplanted into the CSF space of rats. The rats we re expected to ex h i b i t a n a l gesic effects because the secreted ␤-e n d o rphin fro m e n c ap s u l ated cells binds opiate re c ep t o rs in the spinal c o rd. 2 6 Th ree measures (tail-pinch test, hot-plate test, and e l e c t rical stimu l ation) we re used to eva l u ate possible analgesic effects associated with the ␤-e n d o rp h i n -s e c re t i n g cells. This ex p e riment is the fi rst in wh i ch encap s u l at e d tumor cell lines secreting opiate we re transplanted into the CSF space. This study was ap p roved by the Institutional C a re and Use Committee.
Materials and Methods

Cell Encapsulation
The mouse pituitary tumor cell line AtT-20 5 and the mouse neuroblastoma cell line proopiomelanocortin gene-transfected N e u r o 2 A 1 3 (gift from Dr. Boileau), 1 6 both of which secrete ACTH and ␤-endorphin, were used for encapsulated transplantation. The experimental animals were divided into three groups, AtT-20 (five rats), Neuro2A (eight), and control (eight).
Polymer capsules (PM30; inner diameter, 500 m; length, 15 mm) were used for transplantation. This capsule was permeable to molecules below 30 kD. The tumor cells were suspended in phosphate-buffered saline (PBS) at a density of 5 ϫ 1 0 6 cells/ml. After injection of tumor cell suspension into the polymer capsule, both ends were heat sealed. Polymer capsules for control implants (control group) were filled with the conditioned culture medium. 
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Analgesia induced by transplantation of encapsulated tumor cells secreting ␤-endorphin
In Vitro Experiments
Cell line AtT-20 was maintained in Ham's F10 medium containing 15% horse serum and 2.5% fetal bovine serum, and Neuro2A was maintained in Dulbecco's modified Eagle's medium containing 5% horse serum, 10% fetal bovine serum and 100 g/ml geneticin. Simultaneously with the implantation of polymer capsules in the CSF space of experimental animals, both tumor cell lines were suspended in PBS at a density of 5 ϫ 1 0 6 cells/ml and encapsulated in 3-cm long polymer capsules (five pieces of each tumor cell). These capsules were then incubated in each conditioned culture medium (3 ml). On Days 3, 10, 17, 24, and 31 after encapsulation, the medium was changed, and the capsule was incubated for 24 hours. The concentrations of ACTH secreted from the tumor cells as they incubated in the media were measured by radioimmunoassay.
Transplantation Surgery
Young adult male Sprague-Dawley rats each weighing 300 g were anesthetized by intraperitoneal injection of 60 mg/kg of sodium pentobarbital. Under an operative microscope, the occipitoatlantal junction was exposed, dura mater and arachnoid membrane were incised, and a capsule was implanted into the subarachnoid space of the spinal cord. The animals in the control group received the polymer capsules without cells. In some animals, subarachnoid bleeding occurred at the time of insertion of the capsule. The animals that had massive bleeding in the CSF space or showed motor abnormalities following the surgical procedures were eliminated from the study. The remaining animals were returned to their cages and allowed free access to food and water. They were tested for pain sensitivities at 2 and 4 weeks after the transplantation.
Analgesiometric Tests
The tests included the tail-pinch test, hot-plate test, and electrical stimulation. For the tail-pinch test, a homeostatic clip (1 kg constant pressure) was applied to the root of the rat's tail. 1 2 N o c i c e p t i v e responses were measured by latency of the biting response to the clip. In the absence of a response, the clip was removed after 10 seconds to prevent tissue damage and assigned a tail-pinch latency of 10 seconds. Hot-plate test response was determined by placing the rat on a 55˚C plate enclosed in a plexiglass cylinder. The interval between placement on the hot plate and the response of either licking the hind paws or jumping off the plate is defined as the "hot-plate latency." 2 1 Neuromuscular electrical stimulation* was performed on the hind leg. 9 The voltage was increased sequentially until the animal reacted with a withdrawal response. The animals were initially screened for baseline pain sensitivities. The six Neuro2A-implanted animals received 1 mg/kg body weight of naloxone, given intramuscularly 1 day after the test for pain sensitivity at 4 weeks. One-half hour after the naloxone injection, pain sensitivity was assessed again using the three analgesiometric tests.
Morphological Examination and Radioimmunoassay
After the analgesiometric tests, the animals with polymer capsules were killed with an overdose of sodium pentobarbital, and the polymer capsules were removed. The encapsulated tumor cells were embedded in paraffin. Sections 5 m thick were cut and mounted on glass slides, stained with H & E, and studied under light microscopy. The concentrations of ACTH and ␤-endorphin in the media were measured by Allegro kit. † Anti-␤-e n d o r p h i n immunoglobulin G was originally raised in rabbits by several subcutaneous injections of synthetic human ␤-e n d o r p h i n .
Statistical Analysis
Mean and standard deviation or standard error of the mean were calculated for each time point and group in the analgesiometric tests. Data were subjected to analysis of variance corrected for repeated measures on two factors (treatment and time), followed by Newman-Keuls' test for multiple comparisons. The paired t-test was used to compare the responses to analgesiometric tests before and after naloxone injection.
Results
In vitro d ata are summari zed in Fi g. 1. The ratio of ACTH and ␤-e n d o rphin secretions was consistent in each cell line throughout the study. The ratio was 1:0.12 Ϯ 0 . 0 2 in AtT-20 (five capsules) and 1:0.82 Ϯ 0.09 in Neuro 2 A ( five capsules). A few weeks after encap s u l ation, tumor cells continued to secrete peptides. Ten days after encaps u l ation, the concentrations of the peptides in the media of both tumor cell lines we re maximum. As late as 31 day s after encap s u l ation, the peptide secretion was as high as t h at of Day 3 in Neuro 2 A .
In the in vivo s t u dy, rats in both groups (AtT-20, five animals; Neuro2A, eight animals) revealed signifi c a n t ______________ a n a l gesia in comparison with the control group and pret ransplanted animals, ex c ept for the hot-plate test and e l e c t rical stimu l ation at 4 weeks after implantation in the A t T-20 groups (Table 1, Fi g. 2). Th e re was no significant diffe rence between pain sensitivity at 2 weeks and 4 weeks in each group. The intra muscular injection of naloxone produced the same pain sensitivity as in control animals at 4 weeks in the Neuro2A group (Fi g. 3) .
In pre l i m i n a ry study, two rats in the AtT-20 gro u p had massive bleeding in the CSF space at the time of capsule implantation. These two revealed a poor response to a n a l ge s i o m e t ric tests (hot-plate test: 5.1, 3.6 seconds, tailp i n ch test: 1.7, 1.0 seconds, electrical stimu l ation: 20, 20 V, re s p e c t ive ly) at 2 weeks after the tra n s p l a n t ation. At a u t o p s y, the capsules we re found to be cove red with conn e c t ive tissue (Fi g. 4) . Th e re fo re, the animals with bl e e ding in the CSF space at the time of implant we re pro s p e ct ive ly re m oved from the study.
M o rp h o l ogical study revealed that the tumor cells in the c apsules surv ived but aggregat e d, and the core of the s p h e roid was necro t i c. The tumor cells in outer laye rs of the spheroid in the capsules surv ived 1 month after the implant (Fi g. 5). Analgesic effects we re provided to these animals by the cap s u l e s .
Discussion
In this study, rats that had re c e ived implants of enc ap s u l ated ␤-e n d o rp h i n -s e c reting cells (AtT-20 and Neuro2A) into the CSF space revealed significant analgesia at 2 and 4 weeks after implantation. This effect was reve rs e d by the opiate antagonist, nalox o n e. The viability of encaps u l ated tumor cells was confi rmed by morp h o l ogi c a l ex a m i n ation after the testing of pain sensitivity given at 4 weeks. The in vitro s t u dy revealed that the encap s u l at e d tumor cells kept secreting peptides for 1 month.
O p i ates are ve ry effe c t ive in reduction of pain. It has been shown that ␤-e n d o rphin is 21 times more potent as an opiate than morp h i n e 2 5 and that it has induced analgesia when injected intrave n o u s ly either in animals 3 o r in humans. 7 I n t rathecal administration of ␤-e n d o rphin at the lumbar level induced prominent analgesic effe c t s . 1 7 , 2 4 Injection of opiate into the CSF space at the lumbar leve l is more beneficial than injection into ve n t ri cles, because i n t rave n t ricular injection of opiate induces activation of b rain opiate re c ep t o rs, and the patients develop drow s iness, mental cl o u d i n g, and ch a n ges in mood. 2 0 Th e re fo re, va rious altern at ive methods for delive ry of opiates into the CSF we re tried for the tre atment of pain. 4 , 1 8 Th ey concluded that continuous infusion is more effe c t ive than bolus injection for long-term pain contro l . 1 9 L o n g -t e rm a d m i n i s t ration of low doses of opiate to the pat i e n t 's spinal cord caused analgesia without the development of tole rance or the side effects that occur with activation of b rain opiate re c ep t o rs . 1 9 , 2 0 In the present study, encap s ul ated ␤-e n d o rp h i n -s e c reting tumor cells we re implanted in the CSF space and induced an analgesic effect on the host animals for 1 month. This transplant system may be of peptides from cytoplasm, caused by the collapse of cells located deep within the spheroids. One month after e n c ap s u l ation, secretion from the encap s u l ated cells wa s almost the same as that just after the encap s u l ation (see Fi g. 1). Adre n o c o rt i c o t ropic hormone and ␤-e n d o rp h i n a re processed from pro o p i o m e l a n o c o rtin (pre c u rsor peptide), and the ratio of the production of these substances is thought to be consistent in AtT-20 and Neuro2A. In our s t u dy, the AC T H /␤-e n d o rphin ratio was 1:0.12 Ϯ 0.02 in A t T-20 and was 1:0.82 Ϯ 0.09 in Neuro2A. Confi rm at i o n of peptide secretion from the tumor cells in the cap s u l e s was perfo rmed by measuring the level of ACTH in the c u l t u re media.
S agen and colleag u e s 2 1 rep o rted that transplants of ch ro m a ffin cells to the spinal CSF space provided analgesia in rats. Th ey suggested that the combination of cat echolamines and enkephalin secreted from ch ro m a ffin cells was the basis for analgesia. Some re s e a rch e rs are using e n c ap s u l ated bovine ch ro m a ffin cells to eva l u ate their e ffe c t iveness for the tre atment of cancer pain (Ly s aght, e t a l., unpublished data). It will be ve ry important to comp a re the effects on pain control of ch ro m a ffin cells and our tumor cell lines secreting ␤-e n d o rphin. In the near future, these implant systems may be applied to the clinical tre atment of cancer pain.
